Back
Vanda Pharmaceuticals Vs. Zevra Therapeutics Industry Stock Comparison
Sell
23
VNDA
Vanda Pharmaceuticals
Last Price:
4.62
Seasonality Move:
8.6%
Buy
52
ZVRA
Zevra Therapeutics
Last Price:
7.20
Seasonality Move:
-10.58%
Sell
23
Vanda Pharmaceuticals (VNDA)
is a Sell
Is Vanda Pharmaceuticals a Buy, Sell or Hold?
- The current Vanda Pharmaceuticals [VNDA] share price is $4.63. The Score for VNDA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- VNDA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Zevra Therapeutics (ZVRA)
is a Buy
Is Zevra Therapeutics a Buy, Sell or Hold?
- The current Zevra Therapeutics [ZVRA] share price is $7.20. The Score for ZVRA is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- ZVRA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VNDA Stock Price Chart
What is Vanda Pharmaceuticals's stock price today?
-
The Vanda Pharmaceuticals share price today is $4.63
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VNDA is experiencing slight buying pressure.
ZVRA Stock Price Chart
What is Zevra Therapeutics's stock price today?
-
The Zevra Therapeutics share price today is $7.20
The current trend is relatively stagnant and ZVRA is experiencing slight selling pressure.
VNDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 40.12 | Sell |
| Chaikin Money Flow: | 67272 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.66 - 5.08) | Sell |
| Bollinger Bands (100): | (4.9 - 5.92) | Sell |
ZVRA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 48.14 | Sell |
| Chaikin Money Flow: | -166751 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.09 - 7.81) | Sell |
| Bollinger Bands (100): | (4.86 - 7.38) | Buy |
VNDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.65 | Sell |
| 20-day SMA: | 4.81 | Sell |
| 50-day SMA: | 5.13 | Sell |
| 200-day SMA: | 4.82 | Sell |
| 8-day EMA: | 4.64 | Sell |
| 20-day EMA: | 4.8 | Sell |
| 50-day EMA: | 5.06 | Sell |
| 200-day EMA: | 5.12 | Sell |
ZVRA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.13 | Buy |
| 20-day SMA: | 7.47 | Sell |
| 50-day SMA: | 7.21 | Sell |
| 200-day SMA: | 5.89 | Buy |
| 8-day EMA: | 7.22 | Sell |
| 20-day EMA: | 7.33 | Sell |
| 50-day EMA: | 7.05 | Buy |
| 200-day EMA: | 6.03 | Buy |
Vanda Pharmaceuticals Earnings Growth & VNDA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Zevra Therapeutics Earnings Growth & ZVRA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and an increase next year of $1.08 per share.
Vanda Pharmaceuticals Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zevra Therapeutics Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||